Matthew Schultz - Concepedia

Author

Matthew Schultz

Mayo Clinic ORCID

Also Known As

M. Schultz, Matthew J Schultz, Matthew J. Schultz, Matthew Schultz, Schultz, Matthew, Schultz, Matthew J

126

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Florida University of Alabama at Birmingham Cincinnati Children's Hospital Medical Center University of Washington

About

Matthew Schultz is an author at Mayo Clinic specializing in medicine, pathology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	238
2	Engineering	3	3	151
3	Biomedical Engineering	2	2	134
4	Education	1	1	13
5	Social Sciences	1	1	13

Matthew Schultz

Publications

799

Citations

H-Index

Page 1

	Year	Citations
ST6Gal-I Protein Expression Is Upregulated in Human Epithelial Tumors and Correlates with Stem Cell Markers in Normal Tissues and Colon Cancer Cell Lines Amanda F. Swindall, Angelina I. Londoño-Joshi, Matthew Schultz, Cancer Research	2013	163
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype Matthew Schultz, Andrew T. Holdbrooks, Asmi Chakraborty, Cancer Research	2016	159
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells Matthew Schultz, Amanda F. Swindall, John W. Wright, Journal of Ovarian Research	2013	112
Microporous Dermal-Mimetic Electrospun Scaffolds Pre-Seeded with Fibroblasts Promote Tissue Regeneration in Full-Thickness Skin Wounds Paul P. Bonvallet, Matthew Schultz, Elizabeth Mitchell, PLoS ONE Tissue EngineeringEngineeringElectrospun ScaffoldBiomaterials DesignBiofabrication	2015	74
Microporous Dermal-Like Electrospun Scaffolds Promote Accelerated Skin Regeneration Paul P. Bonvallet, Bonnie K. Culpepper, Jennifer Bain, Tissue Engineering Part A Tissue EngineeringEngineeringBiomaterials DesignBiofabricationDermal Structure	2014	60
Tracer metabolomics reveals the role of aldose reductase in glycosylation Silvia Radenkovic, Anna N. Ligezka, Sneha S. Mokashi, Cell Reports Medicine	2023	31
De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy Muhammad A. Usmani, Zubair M. Ahmed, Pamela Magini, The American Journal of Human Genetics Neurodevelopmental DisordersAllelic VariantDevelopmental BiologyGenetic DisorderGenetics	2021	28
UBA2 variants underlie a recognizable syndrome with variable aplasia cutis congenita and ectrodactyly Rhonda E. Schnur, Sairah Yousaf, James Liu, Genetics in Medicine Uba2 VariantsDevelopmental BiologyMendelian DisorderGenetic DisorderGenetics	2021	18
Abstract 916: Combined genomic and epigenomic assessment of cell-free circulating tumor DNA (ctDNA) improves assay sensitivity in early-stage colorectal cancer (CRC) Seung-Tae Kim, Victoria M. Raymond, Joon Oh Park, Cancer Research EngineeringEpigenetic ChangePathologyBiomarker TestingEpigenetics	2019	17
Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions Karthik Muthusamy, Judit Perez Ortiz, Anna N. Ligezka, Genetics in Medicine Pmm2-congenital DisordersFuture DirectionsMedicineNeurological DisorderInherited Metabolic Disease	2023	17

Page 1